THE PROGNOSTIC VALUE OF IMMUNOCYTOCHEMICAL (ICC) ANALYSIS ON BONE-MARROW (BM) TAKEN FROM PATIENTS WITH STAGE II III BREAST-CANCER UNDERGOING AUTOLOGOUS TRANSPLANT (ABMT) THERAPY/
J. Moreb et al., THE PROGNOSTIC VALUE OF IMMUNOCYTOCHEMICAL (ICC) ANALYSIS ON BONE-MARROW (BM) TAKEN FROM PATIENTS WITH STAGE II III BREAST-CANCER UNDERGOING AUTOLOGOUS TRANSPLANT (ABMT) THERAPY/, Blood, 90(10), 1997, pp. 1703-1703